Who invested in 98point6?
98point6's investors include Goldman Sachs, L Catterton and Activant Capital.

United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$102Mraised across 3 rounds since 2017, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
98point6Biotech/health1 / 15Their pitch deck98point6's pitch deck, 15 slidesEach slide read for what it argues, against the decks that raised at the same stage.→Source recordedSEC filing: $31M sold, first sale Mar 2023
No investor was named in the report.
Reported by FinSMEsSEC filing: $29M sold, first sale Sept 2017
From the SEC filings it signed: 2 on the team.
On the board, as filediDavid ViniarJim SinegalLaurence FinkMichael FarelloNader NainiRegina BenjaminSarah Smith
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
98point6's investors include Goldman Sachs, L Catterton and Activant Capital.
98point6 has raised $102M across 3 rounds since 2017.
98point6's most recent round was a Debt of $32M in Apr 2023.
98point6's largest round on record is $50M (Series C), in Oct 2018.
98point6's first round on record, in Oct 2018, was backed by Goldman Sachs.
98point6's latest named round is a Debt, in Apr 2023.
98point6 is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.